In vitro glucuronidation of the angiotensin II receptor antagonist telmisartan in the cat: A comparison with other species

Journal of Veterinary Pharmacology and Therapeutics

Volumn 36, Issue 2, 2013, Pages 154-160

  Ebner, T ^a   Schanzle G ^a   Weber, W ^a   Sent, U ^a   Elliott, J ^b  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; GLUCURONOSYLTRANSFERASE 1A6; GLUCURONOSYLTRANSFERASE 1A7; GLUCURONOSYLTRANSFERASE 1A8; GLUCURONOSYLTRANSFERASE 1A9; TELMISARTAN;

ANIMAL CELL; ARTICLE; CAT; CONTROLLED STUDY; DRUG CLEARANCE; DRUG GLUCURONIDATION; DRUG METABOLISM; FEMALE; HUMAN; IN VITRO STUDY; LIVER MICROSOME; MALE; MICHAELIS MENTEN KINETICS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANGIOTENSIN RECEPTOR ANTAGONISTS; ANIMALS; BENZIMIDAZOLES; BENZOATES; CATS; DOGS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCURONOSYLTRANSFERASE; HUMANS; MALE; MICROSOMES, LIVER; MOLECULAR STRUCTURE; RATS; SPECIES SPECIFICITY;

CANIS FAMILIARIS; FELIDAE; MAMMALIA; RATTUS;

EID: 84874930009     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2012.01398.x     Document Type: Article

References (28)

1. Adamson, R.H., Bridges, J.W., Kibby, M.R., Walker, S.R. & Williams, R.T. (1970) The fate of sulphadimethoxine in primates compared with other species. Biochemical Journal, 118, 41-45.
2. Brown, S.A., Brown, C.A., Jacobs, G., Stiles, J., Hendi, R.S. & Wilson, S. (2001) Effects of the angiotensin converting enzyme inhibitor benazepril in cats with induced renal insufficiency. American Journal of Veterinary Research, 62, 375-383.
3. Burnier, M. & Brunner, H.R. (2000) Angiotensin II receptor antagonists. The Lancet, 355, 637-645.
4. Caldwell, J., Williams, T., Bassir, O. & French, M.R. (1978) Drug metabolism in "exotic" animals. European Journal of Drug Metabolism and Pharmacokinetics, 2, 61-66.
5. Cladwell, J., Weil, A. & Tanaka, Y. (1989). Species Differences in Xenobiotic Conjugation. In Xenobiotic Metabolism and Disposition. Eds Kato, R., Estabrook, R.W. & Cayen, M.N., pp. 217-224. Taylor & Francis, London, New York, Philadelphia.
6. Court, M.H. & Greenblatt, D.J. (1997) Molecular basis for deficient acetaminophen glucuronidation in cats. An interspecies comparison of enzyme kinetics in liver microsomes. Biochemical Pharmacology, 53, 1041-1047.
7. Court, M.H. & Greenblatt, D.J. (2000) Molecular genetic basis for deficient acetaminophen glucuronidation by cats: UGT1A6 is a pseudogene, and evidence for reduced diversity of expressed hepatic UGT1A isoforms. Pharmacogenetics, 10, 355-369.
8. Ebner, T. & Burchell, B. (1993) Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family. Drug Metabolism and Disposition, 21, 50-55.
9. Ebner, T., Heinzel, G., Prox, A., Beschke, K. & Wachsmuth, H. (1999) Disposition and chemical stability of telmisartan 1-O-acylglucuronide. Drug Metabolism and Disposition, 27, 1143-1149.
10. Fisher, M.B., Campanale, K., Ackermann, B.L., Vandenbranden, M. & Wrighton, S.A. (2000) In vitro glucuronidation using human liver microsomes and the pore- forming peptide alamethicin. Drug Metabolism and Disposition, 28, 560-566.
11. Hietanen, E. & Vainio, H. (1973) Interspecies variations in small intestinal and hepatic drug hydroxylation and glucuronidation. Acta Pharmacologica et Toxicologica, 33, 57-64.
12. Houston, J.B. & Carlile, D.J. (1997) Incorporation of in vitro drug metabolism data into physiologically-based pharmacokinetic models. Toxicology in Vitro, 11, 473-478.
13. Jansen, P.L.M. (1974) The enzyme catalyzed formation of bilirubin diglucuronide by a solubilized preparation from cat liver microsomes. Biochimical Biophysical Acta, 338, 170-182.
14. Jepson, R.E., Elliott, J., Brodbelt, D. & Syme, H.M. (2007) Effects of control of systolic blood pressure on survival in cats with systemic hypertension. Journal of Veterinary Internal Medicine, 3, 402-409.
15. King, J.N., Gunn-Moore, D.A., Tasker, S., Gleadhill, A., Strehlau, G., Ash, R.A., Bussadori, C., Bonfanti, U., Papadopulo, I., Santilli, S., Ghibaudo, G., Lanore, D., Clarke, D.D., Gleadhill, A., Gunn-Moore, D.A., Mackin, A., Tasker, S., Varga, K., Cotard, J.P., Jacquemin, N., Crowe, I.D., Rousselot, J.F., Stonton, S.A., De Geyer, G., Dossin, O., Hagege, G., Arthur, J., Brovida, C., Pechereau, D., Martel, P., Closa, J.M., Font, A., Laforge, H., Piette, M.H. & Do Chi, T. (2006) Tolerability and efficacy of benazepril in cats with chronic kidney disease. Journal of Veterinary Internal Medicine, 20, 1054-1064.
16. Leakley, J.E.A. (1978) An improved assay technique for uridine diphosphate glucuronyltransferase activity towards 5-hydroxytryptamine and some properties of the enzyme. Biochemical Journal, 175, 1119-1124.
17. Lefebvre, H.P. & Toutain, P.L. (2004) Angiotensin-converting enzyme inhibitors in the therapy of renal diseases. Journal of Veterinary Pharmacology and Therapeutics, 27, 265-281.
18. Maschio, G., Alberti, D., Janin, G., Locatelli, F., Mann, J.F., Motolese, M., Ponticelli, C., Ritz, E. & Zucchelli, P. (1996) Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. The New England Journal of Medicine, 334, 939-945.
19. Osikowska-Evers, B.A. & Eichelbaum, M. (1986) A sensitive capillary GC assay for the determination of sparteine oxidation products in microsomal fractions of human liver. Life Science, 38, 1775-1782.
20. Schillings, R.T., Sisenwine, S.F., Schwartz, M.H. & Ruelius, H.W. (1975) Lorazepam: Glucuronide formation in the cat. Drug Metabolism and Disposition, 3, 85-88.
21. Segel, I.H. (1993) Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems. John Wiley & Sons, Inc, New York.
22. Smith, P.K., Krohn, R.I. & Hermanson, G.T. (1985) Measurement of protein using bicinchoninic acid. Analytical Biochemistry, 150, 76-85.
23. Soars, M.G., Ring, B.J. & Wrighton, S.A. (2003) The effect of incubation conditions on the enzyme kinetics of UDP-glucuronosyltransferases. Drug Metabolism and Disposition, 31, 762-767.
24. Syme, H.M., Markwell, P.J., Pfeiffer, D.U. & Elliott, J. (2006) Survival of cats with naturally occurring chronic renal failure is related to severity of proteinuria. Journal of Veterinary Internal Medicine, 20, 528-535.
25. Tanaka, N., Miyasho, T., Shinkyo, R., Sakaki, T. & Yokota, H. (2006) cDNA cloning and characterization of feline CYP1A1 and YP1A2. Life Science, 79, 2463-2473.
26. Wienen, W., Entzeroth, M., van Meel, J.C.A., Stangier, J., Busch, U., Ebner, T., Schmid, J., Lehmann, H., Matzek, K., Kempthorne-Rawson, J., Gladigau, V. & Hauel, N.H. (2000) A review on telmisartan: a novel, long-acting angiotensin II-receptor antagonist. Cardiovascular Drug Reviews, 18, 127-154.
27. Wolf, A.M. (2006). Chronic progressive renal disease in the cat: recognition and management. North American Veterinary Conference, January 7-11, Orlando, Florida.
28. Yamada, A., Maeda, K., Tsuda, Y., Ishiguro, N., Igarashi, T., Ebner, T., Roth, W., Ikushiro, S. & Sugiyama, Y. (2011) The impact of pharmacogenetics of metabolic enzymes and transporters on the pharmacokinetics of telmisartan in healthy volunteers. Pharmacogenetics and Genomics, 21, 523-530.